Microbe-Lift / BMC kills developing mosquitoes before they become breeding, biting adults, including those which may transmit WEST NILE VIRUS and EQUINE ENCEPHALITIS, and those which may transmit HEARTWORM DISEASE to dogs and cats.

MICROBE-LIFT / BMC can be applied to areas that can contain life, fish and plants.

MICROBE-LIFT / BMC can be applied to areas used by or in contact with humans, animals, livestock, pets, birds, or wildlife

Benefits

Biological Larvicide ( B.T.I. Active Ingredient) (see below)

Can be used in watergardens that contain live fish and plants

540 Square foot coverage per teaspoon

Up to 14 days activity depending on application site

Disperses evenly in water

No fish toxicity

No toxicity to non-target invertebrates

No potential for resistance development in the target mosquito population.

No adverse aesthetics to the pond

No organic or inorganic residues

Compare Microbe-Lift/ BTI Formulations to the Competition

Product Attributes	Chemical (S)-Methoprene Pre-Strike	Biological Microbe-lift Liquid Mosquito Control	Biological Mosquito Dunks
Larvae Affected	Older Larvae	ALL Stages except prepupae	All stages except prepupae
Application Frequency	Every 3 Weeks	7-14 days depending on application site	Monthly
Effect on Food Chain	no adverse effect	no adverse effect	no adverse effect
Application Rate	1 teaspoon treats 211sq.ft ( total water column)	1 teaspoon treats 540 sq.ft. (total water column)	1 dunk treats 100 sq.ft. (surface area only)
Product Activity	Works by contact and ingestion	Works by ingestion	Works by ingestion
Application Dispersal	Disperses evenly in water	Disperses evenly in water	Disperses slowly in water
Fish Toxicity	YES if not used according to label	NO	NO
Toxicity against Non-Target Invertebrates	Yes	NO	NO
Potential for resistance development in the Target Mosquito Population	Yes++	NO	NO
Adversely Affects Pond Aesthetics	NO	NO	Yes
Adversely Affects Birdbaths and Fountain Aesthetics	Yes	NO	Yes
Laves Organic and Inorganic Residues	Yes	NO	Yes
Safety	Nearly as safe as BTI Products	Safer than Methoprene	Safer than Methoprene

++ It is essentially impossible to see BTI resistant populations of mosquitoes, while Methoprene resistant populations of insect already exist!

Mosquitoes - and the pathogens they carry .. have proven to be hardy and relentless.

Despite all our technology and science, mosquitoes pose a health risk all over the world.

There are over 2,500 different species of mosquitoes

West Nile

The main WEST NILE VECTOR .. Culex Pipiens .. feeds at night and breeds only in foul, stagnant water. Anything that might hold water (ie: old tires, birdbaths, ponds, water fountains, statuary, drains, rain barrels, stock tanks, abandoned pools ) require attention to limit breeding. It is possible that the West Nile Virus may be transmitted by other types of mosquitoes. There are Perturbans that breed in fresh water, cattail swamps; Sollicitans that breed in salt marshes; Vexans that breed in temporary rain pools, and others that may transmit diseases.

THE ACTIVE INGREDIENT .. BTI

BACILLUS THURINGIENSIS ISRAELENSIS (BTI) is a microbial preparation that is uniquely safe because its toxins act solely on mosquitoes and their close relatives .. black flies, nuisance flies and nuisance aquatic midges. The BTI destroy the wall of the larva's gut. BTI is universally accepted as an example of an environmentally- friendly insecticidal product. It is essentially impossible to see BTI resistant populations of mosquitoes, while Methoprene resistant populations of insects already exist!

West Nile Virus Background Information

Since West Nile virus (WNV) was first isolated in 1937, it has been known to cause asymptomatic infection and fevers in humans in Africa, West Asia, and the Middle East. Human and animal infections were not documented in the Western Hemisphere until 1999. In 1999 and 2000, outbreaks of WNV encephalitis (inflammation of the brain) were reported in persons living in the New York City metropolitan area, New Jersey, and Connecticut. In these two years, 83 human cases of West Nile illness were reported; 9 died. In 2001, human infection with WNV occurred in 10 states with 66 cases and 9 deaths. In 2002, WNV activity spread to 48 states, with 4,156 human cases and 284 deaths.

WNV is transmitted to humans through mosquito bites. Mosquitoes become infected when they feed on infected birds that have high levels of WNV in their blood. Infected mosquitoes can then transmit WNV when they feed on humans or other animals.

WNV is not transmitted from person to person and there is no evidence that a person can get infected by handling live or dead infected birds. But, to add a further level of safety, if birds or other potentially infected animals must be handled, a protective barrier (e.g., gloves, inverted plastic bags) should be used.

Most WNV infected humans have no symptoms. A small proportion develops mild symptoms that include fever, headache, body aches, skin rash and swollen lymph glands. Less than 1% of infected people develop more severe illness that includes meningitis (inflammation of one of the membranes covering the brain and spinal cord) or encephalitis. The symptoms of these illnesses can include headache, high fever, neck stiffness, stupor, disorientation, coma, tremors, convulsions, muscle weakness, and paralysis. Of the few people that develop encephalitis, a small proportion die but, overall, this is estimated to occur in less than 1 out of 1000 infections.

There is no specific treatment for WNV infection or vaccine to prevent it. Treatment of severe illnesses includes hospitalization, use of intravenous fluids and nutrition, respiratory support, prevention of secondary infections, and good nursing care. Medical care should be sought as soon as possible for persons who have symptoms suggesting severe illness.